| Abstrakt: |
The article presents information on developments related to the commercial production of live bacteria. Nearly 300 genetic engineers from 17 countries who gathered at Stanford University, Palo Alto, California in 1983 to compare their growing list of biochemical tools predicted that a new bacteria, Bacillus subtilis, may speed the process of commercial production of live bacteria. Scientists around the world first developed chemical tools in the early 1970s that could cut, insert information, and resplice the genetic material of cells E. coli. Vasantha Nagarajan, researcher for Genex Corp., a biotechnology firm, reported that her firm has ability to identify, clone, and transplant into B. subtilis a gene that codes for the enzyme subtilisin. |
